Generation of in vivo activating factors in the ischemic intestine by pancreatic enzymes

被引:86
作者
Mitsuoka, H
Kistler, EB
Schmid-Schönbein, GW [1 ]
机构
[1] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Whitaker Inst Biomed Engn, La Jolla, CA 92093 USA
关键词
rat; splanchnic arterial occlusion; shock; multiple organ failure; microcirculation;
D O I
10.1073/pnas.97.4.1772
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
One of the early events in physiological shock is the generation of activators for leukocytes, endothelial cells, and other cells in the cardiovascular system. The mechanism by which these activators are produced has remained unresolved. We examine here the hypothesis that pancreatic digestive enzymes in the ischemic intestine may be involved in the generation of activators during intestinal ischemia. The lumen of the small intestine of rats was continuously perfused with saline containing a broadly acting pancreatic enzyme inhibitor (6-amidino-2-naphthyl p-guanidinobenzoate dimethanesulfate, 0.37 mM) before and during ischemia of the small intestine by splanchnic artery occlusion. This procedure inhibited activation of circulating leukocytes during occlusion and reperfusion, It also prevented the appearance of activators in portal venous and systemic artery plasma and attenuated initiating symptoms of multiple organ injury in shock. Intestinal tissue produces only low levels of activators in the absence of pancreatic enzymes, whereas in the presence of enzymes, activators are produced in a concentration- and time-dependent fashion. The results indicate that pancreatic digestive enzymes in the ischemic intestine serve as an important source for cell activation and inflammation, as well as multiple organ failure.
引用
收藏
页码:1772 / 1777
页数:6
相关论文
共 35 条
[1]   PHARMACOLOGICAL STUDIES OF FUT-175, NAFAMSTAT MESILATE .1. INHIBITION OF PROTEASE ACTIVITY IN INVITRO AND INVIVO EXPERIMENTS [J].
AOYAMA, T ;
INO, Y ;
OZEKI, M ;
ODA, M ;
SATO, T ;
KOSHIYAMA, Y ;
SUZUKI, S ;
FUJITA, M .
JAPANESE JOURNAL OF PHARMACOLOGY, 1984, 35 (03) :203-227
[2]   Monoclonal antibody to endotoxin attenuates hemorrhage-induced lung injury and mortality in rats [J].
Bahrami, S ;
Yao, YM ;
Leichtfried, G ;
Redl, H ;
Schlag, G ;
DiPadova, FE .
CRITICAL CARE MEDICINE, 1997, 25 (06) :1030-1036
[3]   GRANULOCYTES AND NO-REFLOW PHENOMENON IN IRREVERSIBLE HEMORRHAGIC-SHOCK [J].
BARROSOARANDA, J ;
SCHMIDSCHONBEIN, GW ;
ZWEIFACH, BW ;
ENGLER, RL .
CIRCULATION RESEARCH, 1988, 63 (02) :437-447
[4]   CIRCULATING NEUTROPHIL KINETICS DURING TOLERANCE IN HEMORRHAGIC-SHOCK USING BACTERIAL LIPOPOLYSACCHARIDE [J].
BARROSOARANDA, J ;
CHAVEZCHAVEZ, RH ;
MATHISON, JC ;
SUEMATSU, M ;
SCHMIDSCHONBEIN, GW .
AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 266 (02) :H415-H421
[5]   Neutrophil activation, tumor necrosis factor, and survival after endotoxic and hemorrhagic shock [J].
BarrosoAranda, J ;
Zweifach, BW ;
Mathison, JC ;
SchmidSchonbein, GW .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1995, 25 :S23-S29
[6]  
BOUNOUS G, 1977, GASTROENTEROLOGY, V73, P102
[7]   TUMOR NECROSIS FACTOR/CACHECTIN STIMULATES PERITONEAL-MACROPHAGES, POLYMORPHONUCLEAR NEUTROPHILS, AND VASCULAR ENDOTHELIAL-CELLS TO SYNTHESIZE AND RELEASE PLATELET-ACTIVATING-FACTOR [J].
CAMUSSI, G ;
BUSSOLINO, F ;
SALVIDIO, G ;
BAGLIONI, C .
JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 166 (05) :1390-1404
[8]   Improvement of survival from hemorrhagic shock by enterectomy in rats: Finding to implicate the role of the gut for irreversibility of hemorrhagic shock [J].
Chang, TW .
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 1997, 42 (02) :223-230
[9]   MULTIPLE ORGAN FAILURE - PATHOPHYSIOLOGY AND POTENTIAL FUTURE THERAPY [J].
DEITCH, EA .
ANNALS OF SURGERY, 1992, 216 (02) :117-134
[10]   Attenuation of oxygen free radical formation and tissue injury during experimental inflammation by P-selectin blockade [J].
Delano, FA ;
Forrest, MJ ;
SchmidSchonbein, GW .
MICROCIRCULATION-LONDON, 1997, 4 (03) :349-357